EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR IN PATIENTS WITH HCV GENOTYPE 5 OR 6 INFECTION: AN INTEGRATED ANALYSIS OF PHASE 2 AND 3 STUDIES Yao, B. B., Asselah, T., Frederick, L., Schnell, G., Kowdley, K., Kwo, P. Y., Poordad, F., Kinh Nguyen, Lee, S. S. BMJ PUBLISHING GROUP. 2019: A146–A147

View details for DOI 10.1136/gutjnl-2019-IDDFabstracts.285

View details for Web of Science ID 000472085300282